
KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME
WITH HETEROZYGOUS P.D50N IN THE GJB2 GENE
IN TWO SERBIAN ADULT PATIENTS Kalezić T.1,*, Vuković I.2, Stojković M.1, Stanojlović S.1, Karanović J.3,
Brajušković G.3, Savić-Pavićević D.3 *Corresponding Author: Tanja Kalezić, School of Medicine, University of Belgrade; Clinic for Eye
Disease, University Clinical Centre of Serbia, Address: Pasterova Street No 2 , Tel. +381638148843,
e-mail address: tanjakalezic@gmail.com page: 6
|
PATIENTS AND METHODS
Two unrelated patients with KID syndrome were
studied. Clinical diagnosis was based on dermatological,
hearing and ophthalmological examinations, and confirmed
by molecular genetic analysis of the GJB2 gene.
Molecular genetic testing for GJB2 mutations was
done for both patients and their unaffected first-degree
relatives (mother and sister), while samples of both fathers
were unavailable for analysis. Genomic DNA
was extracted from peripheral blood samples using the
QIAamp DNA Blood Kit (Qiagen, Germany). Exon 2
of the GJB2 gene was amplified by polymerase chain
reaction (PCR) using the following primers: forward
(5’ GGTGAGGTTGTGTAAGAGTTGG 3’) and reverse
(5’ TGGGTTTTGATCTCCTCGAT 3’), which were designed
by opensource Primer3 software.8 Bidirectional
Sanger sequencing was performed by BigDye® Terminator
v3.1 Cycle Sequencing kit (Life Technologies, USA) and
sequencing data was analyzed using the BioEdit Sequence
Alignment Editor.9
Detailed ophthalmological examination and follow
up for both patients were done in April 2020 at the Clinic
for Eye Disease, University Clinical Center of Serbia,
Belgrade, Serbia. Both patients were treated with topical
steroids (Prednisolone 0.5% q.i.d.) and artificial tears
(HPMC 0.3% preservative free q.h.) for three months,
and the therapy was intensified with topical Prednisolone
0.5% q.h. per day during the fourth month. Patients were
followed up for six months.
|
|
|
|



 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|